Use of antidepressants in patients with moderate-to-severe Crohn's disease

被引：0
|
作者：
Lichtenstein, GR
Colombel, JF
Yan, S
Bala, M
Olson, A
机构：
[1] Univ Penn, Philadelphia, PA 19104 USA
[2] Hop Calmette, Lille, France
[3] Centocor Inc, Malvern, PA 19355 USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2004年 / 99卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
773
引用
收藏
页码：S250 / S251
页数：2
相关论文
共 50 条
  • [31] Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children
    Hyams, Jeffrey
    Crandall, Wallace
    Kugathasan, Subra
    Griffiths, Anne
    Olson, Allan
    Johanns, Jewel
    Liu, Grace
    Travers, Suzanne
    Heuschkel, Robert
    Markowitz, James
    Cohen, Stanley
    Winter, Harland
    Veereman-Wauters, Gigi
    Ferry, George
    Baldassano, Robert
    GASTROENTEROLOGY, 2007, 132 (03) : 863 - 873
  • [32] Changes of fecal calprotectin concentrations after adalimumab induction therapy in patients with moderate-to-severe Crohn's disease
    Lee, K. -M.
    Yang, S. -K.
    Kim, H. J.
    Kim, Y. H.
    Song, G. A.
    Im, J. P.
    Jang, B. I.
    Jung, S. -A.
    Jeen, Y. T.
    Koo, J. S.
    Cheon, J. H.
    Park, S. J.
    Kim, Y. J.
    Eun, C. S.
    Kim, T. -O.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S362 - S362
  • [33] Memantine in moderate-to-severe Alzheimer's disease
    Reisberg, B
    Doody, R
    Stoffler, A
    Schmitt, F
    Ferris, S
    Mobius, HJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14): : 1333 - 1341
  • [34] Memantine in moderate-to-severe Alzheimer's disease
    Bleich, S
    Wiltfang, J
    Kornhuber, J
    NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (06): : 609 - 610
  • [35] EFFICACY AND SAFETY OF OPEN-LABEL MAINTENANCE THERAPY WITH SUBCUTANEOUS RISANKIZUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
    Feagan, Brian G.
    Panes, Julian
    Ferrante, Marc
    Kaser, Arthur
    D'Haens, Geert R.
    Sandborn, William J.
    Louis, Edouard
    Neurath, Markus
    Franchimont, Denis
    Dewit, Olivier
    Seidler, Ursula
    Kim, Kyung-Jo
    Selinger, Christian
    Padula, Steven J.
    Herichova, Ivona
    Robinson, Anne M.
    Wallace, Kori
    Zhao, Jun
    Soaita, Adina
    Visvanathan, Sudha
    Hall, David
    Bocher, Wulf O.
    GASTROENTEROLOGY, 2017, 152 (05) : S1310 - S1310
  • [36] EFFICACY AND SAFETY OF MIRIKIZUMAB AFTER 52-WEEKS MAINTENANCE TREATMENT IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
    Sands, Bruce E.
    Sandborn, William J.
    Peyrin-Biroulet, Laurent
    Higgins, Peter D.
    Hirai, Fumihito
    Jairath, Vipul
    D'Haens, Geert
    Abreu, Maria T.
    Belin, Ruth
    Valderas, Elisa Gomez
    Miller, Debra
    Naegeli, April N.
    Arora, Vipin
    Pollack, Paul
    Tuttle, Jay
    Hibi, Toshifumi
    GASTROENTEROLOGY, 2021, 160 (06) : S37 - S37
  • [37] IMPROVED PATIENT-REPORTED OUTCOMES WITH UPADACITINIB OVER 52 WEEKS IN PATIENTS WITH MODERATE-TO-SEVERE CROHN'S DISEASE
    Peyrin-Biroulet, L.
    Louis, E.
    Loftus, E. V., Jr.
    Lee, W. J.
    Cataldi, F.
    Lacerda, A.
    Ghosh, S.
    GUT, 2019, 68 : A195 - A195
  • [38] Pharmacoeconomics of antidepressants in moderate-to-severe depressive disorder in Colombia
    Machado, Marcio
    Maria Lopera, Monica
    Diaz-Rojas, Jorge
    Eduardo Jaramillo, Luis
    Einarson, Thomas Ray
    REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 24 (04): : 233 - 239
  • [39] Pharmacokinetics of Laquinimod in Patients With Active Moderate to Severe Crohn's Disease
    D'Haens, Geert R.
    Sandborn, William
    Colombel, Jean-Frederic
    Mimrod, Dorit
    Spiegelstein, Ofer
    Brown, Kurt
    Feagan, Brian G.
    GASTROENTEROLOGY, 2014, 146 (05) : S368 - S368
  • [40] Pharmacokinetics of laquinimod in patients with active moderate to severe Crohn's disease
    D'Haens, G.
    Sandborn, W. J.
    Rutgeerts, P.
    Colombel, J. F.
    Mimrod, D.
    Spiegelstein, O.
    Brown, K.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S226 - S226
12345